Device Registration Switzerland

Medical device registration in Switzerland follows the Medical Device Ordinance (MedDO). Manufacturers must establish the appropriate conformity assessment, meet applicable technical and quality requirements, comply with Swiss labeling rules, and complete required Swissmedic notifications. Foreign manufacturers must also appoint a Swiss Authorized Representative (CH-REP) before placing devices on the Swiss market.

Yes. Foreign manufacturers must appoint a Swiss Authorized Representative (CH-REP) before placing medical devices or IVDs on the Swiss market. The CH-REP acts as the manufacturer’s legal representative and primary contact with Swissmedic, supports regulatory compliance, maintains required documentation, and assists with vigilance and incident communications.

Swissmedic requirements depend on the device type, classification, and responsible economic operator. Applicable devices require notification through the Swiss system, supported by conformity assessment and appropriate technical documentation. Manufacturers and representatives must also meet MedDO requirements for labeling, lifecycle compliance, vigilance, and ongoing regulatory obligations.

Switzerland classifies medical devices into Class I, Class IIa, Class IIb, and Class III. The classification system is closely aligned with EU MDR principles, with risk-based rules determining the applicable conformity assessment and regulatory pathway. Correct classification is important because it affects documentation, technical assessment, and market-entry requirements.

Swiss MedDO is Switzerland’s national medical device framework and is closely aligned with EU MDR requirements, but Switzerland has its own regulatory obligations. Foreign manufacturers must consider Swiss-specific requirements such as appointing a CH-REP, Swissmedic notifications, and applicable Swiss market documentation rather than assuming EU MDR compliance alone completes Swiss market access.

Medical device information and labeling for the Swiss market must be available in German, French, and Italian, according to the applicable Swiss requirements. Manufacturers should verify that labeling, device information, and related regulatory documentation meet the required language and formatting expectations before placing products on the Swiss market.

A CH-REP acts on behalf of a foreign manufacturer for Swiss regulatory matters and serves as a primary contact with Swissmedic. Responsibilities can include maintaining technical documentation, supporting notifications, coordinating vigilance and incident communications, appointing a PRRC, and helping ensure continued compliance throughout the device lifecycle.

The Swissmedic notification process depends on the type of device and the responsible entity. Applicable manufacturers, CH-REPs, importers, distributors, or other specified parties submit the required notification information and product details. Additional requirements may apply to Class I devices, custom-made devices, repacked products, and other device categories.

In vitro diagnostic devices are regulated under Switzerland’s In-Vitro Diagnostic Ordinance (IvDO). Foreign IVD manufacturers must appoint a CH-REP, while applicable IVDs require Swissmedic notification. Additional notification requirements can apply to self-testing and in-house IVDs, depending on the device type and responsible entity.

ISO 13485:2016 is the quality management standard identified within the Swiss medical device regulatory framework. Manufacturers should maintain an appropriate quality management system and meet applicable conformity assessment requirements under MedDO or IvDO. The specific assessment requirements depend on the device classification, conformity pathway, and applicable regulatory obligations.